Sorafenib and Regorafenib in HBV- or HCV- positive...

  • Main
  • 2017 / 5
  • Sorafenib and Regorafenib in HBV- or HCV- positive...
Digestive and Liver Disease 2017 / 5

Sorafenib and Regorafenib in HBV- or HCV- positive hepatocellular carcinoma patients: analysis of RESORCE and SHARP trials

Casadei Gardini, Andrea, Frassineti, Giovanni Luca, Foschi, Francesco Giuseppe, Ercolani, Giorgio, Ulivi, Paola
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Digestive and Liver Disease
DOI:
10.1016/j.dld.2017.04.022
Date:
May, 2017
File:
PDF, 234 KB
english, 2017
Conversion to is in progress
Conversion to is failed